What is the recommended dosing schedule for carbamazepine and what is its half-life?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Carbamazepine Dosing Schedule and Half-Life

Half-Life

Carbamazepine has a variable half-life that decreases significantly with chronic use due to autoinduction: initially 25-65 hours after first dose, decreasing to 12-17 hours after 3-5 weeks of continuous therapy. 1

  • In children on long-term therapy, the half-life ranges from 6-12 hours, which is shorter than the 15-hour half-life seen in adults 2
  • After single oral doses, the elimination half-life is approximately 35 hours (range 18-65 hours), but this decreases to 10-20 hours during multiple dosing due to autoinduction of oxidative metabolism 3
  • Autoinduction is completed after 3-5 weeks of fixed dosing 1

Dosing Schedule

Adults and Children Over 12 Years

For epilepsy, start with 200 mg twice daily (400 mg/day total), increasing by up to 200 mg/day at weekly intervals using a 3-4 times daily regimen until optimal response is achieved. 1

  • Maximum dose should not exceed 1,000 mg daily in children 12-15 years of age, and 1,200 mg daily in patients above 15 years 1
  • Doses up to 1,600 mg daily have been used in adults in rare instances 1
  • Maintenance dosage is typically 800-1,200 mg daily 1
  • Because of carbamazepine's relatively short half-life (12-17 hours with chronic use), the total dosage should be administered in at least two divided doses to avoid excessively high peak blood levels 4

Children 6-12 Years

Start with 100 mg twice daily (200 mg/day total), increasing by up to 100 mg/day at weekly intervals using a 3-4 times daily regimen. 1

  • Maximum dose generally should not exceed 1,000 mg daily 1
  • Maintenance dosage is typically 400-800 mg daily 1

Children Under 6 Years

Start with 10-20 mg/kg/day divided into 2-3 doses, increasing weekly to achieve optimal clinical response administered 3-4 times daily. 1

  • Maintenance dosage should ordinarily not exceed 35 mg/kg/day 1
  • No recommendation regarding safety at doses above 35 mg/kg/24 hours can be made 1

Trigeminal Neuralgia

Start with 100 mg twice daily (200 mg/day total), increasing by up to 200 mg/day using increments of 100 mg every 12 hours as needed to achieve freedom from pain. 1

  • Do not exceed 1,200 mg daily 1
  • Maintenance dose is typically 400-800 mg daily, though some patients may be maintained on as little as 200 mg daily 1
  • The American Academy of Neurology recommends starting at 200 mg at night with gradual increase of 200 mg every 7 days to a final dose of 400-1,200 mg/day divided into 2-3 doses 5

Therapeutic Monitoring

Therapeutic blood levels should be maintained between 4-8 mcg/mL, with usual adult therapeutic levels between 4-12 mcg/mL. 6, 1

  • The best anticonvulsant effect appears to be obtained at plasma levels of approximately 5-10 mcg/mL (20-40 micromol/L) 3
  • Plasma levels of carbamazepine are variable and may range from 0.5 to 25 mcg/mL, with no apparent relationship to daily intake 1
  • Once seizures are controlled, plasma levels should be measured to establish optimum levels for individual patients 4

Important Administration Details

Medication should be taken with meals. 1

  • A low initial daily dosage with gradual increase is advised 1
  • As soon as adequate control is achieved, dosage may be reduced very gradually to the minimum effective level 1
  • Therapy should begin gradually, with initial doses increased slowly over 1-2 weeks as tolerated to minimize side effects 4

Common Pitfalls

A single daily dose is insufficient; at minimum 2 doses per day are appropriate in most cases, but some patients may benefit from more frequent dosing (3-4 times daily) to avoid side effects related to peak levels. 3

  • Side effects including fatigue, dizziness, ataxia, double vision, nausea, and vomiting are most common during dosage initiation or dose elevation and usually dissipate over time 4, 2
  • Most side effects are dose-related and occur in up to 50% of patients, but usually require no alteration in dosage 2

References

Research

Clinical pharmacokinetics of carbamazepine.

Clinical pharmacokinetics, 1978

Guideline

Carbamazepine as a First-Line Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Carbamazepine Dosage and Monitoring Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.